Cis-3-chloroacrylic acid dehalogenase
coryneform bacterium
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein homooligomer Homooligomer Protein × 3 PDB declaration: trimeric(3) Consistent with protein copy count | Chain A; UniProt 2–150 Chain B; UniProt 2–150 Chain C; UniProt 2–150 | Mutation:E114Q Non-standard monomer:Yes (specific site not provided by mmCIF) | SO4 SULFATE ION × 3 | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;277 K;(0.05 citric acid, 0.05 BIS-TRIS propane) pH 5 20% w/v PEG 3,352 | Resolution 2.20 Å R-free 0.241 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 9YRI | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 3MF7 Crystal Structure of (R)-oxirane-2-carboxylate inhibited cis-CaaD Deposited 2010-04-01 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–150(149 aa)
Fragment:UNP residues 2-118
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
hanging drop;pH 4.6;298 K;three micro liter of 15.6mg/mL cis-CaaD protein sample mixed with three micro liter crystallization solution: 0.125 M CaCl2, 0.07 M sodium acetate buffer, 12.5% isopropanol, hanging drop, temperature 298K, pH 4.6
|
Resolution 1.65 Å R-free 0.222 |
| 3MF8 Crystal Structure of Native cis-CaaD Deposited 2010-04-01 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–150(149 aa)
Fragment:UNP residues 2-118
|
Not recorded | SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
hanging drop;pH 9;298 K;three micro liter of 14 mg/mL cis-CaaD protein sample mixed with three micro liter crystallization solution: 8 M (NH4)2SO4, 0.1 M Bicine buffer (pH 9.0), hanging drop, temperature 298K
|
Resolution 2.01 Å R-free 0.236 |
| 9NF1 cis-CaaD E114D mutant Deposited 2025-02-20 | Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–150(149 aa)
Chain B
2–150(149 aa)
Chain C
2–150(149 aa)
|
Mutation:E114D Mutation:E114D Mutation:E114D | SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;0.2 M ammonium sulfate 20% w/v PEG 3,351
|
Resolution 1.60 Å R-free 0.220 |
| 9NF3 cis-CaaD E114D mutant with a covalent ethylene intermediate of the hydration and decarboxylation of cis-3-chloroacrylic acid Deposited 2025-02-20 | Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–150(149 aa)
Chain B
2–150(149 aa)
Chain C
2–150(149 aa)
|
Mutation:E114D Mutation:E114D Mutation:E114D Non-standard monomer:Yes (specific site not provided by mmCIF) | SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;0.2 M ammonium sulfate 20% w/v PEG 3,353
|
Resolution 1.80 Å R-free 0.224 |
| 9NF9 cis-CaaD E114N mutant apo Deposited 2025-02-21 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
1–150(150 aa)
Chain B
1–150(150 aa)
Chain C
1–150(150 aa)
|
Mutation:E114N Mutation:E114N Mutation:E114N | SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;(0.03 M citric acid, 0.07 M BIS-TRIS propane) pH 7.6
|
Resolution 2.51 Å R-free 0.290 |
| 9NFD cis-CaaD E114N mutant with acetylenecarboxylic acid substrate and hydration product malonic semialdehyde Deposited 2025-02-21 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–150(149 aa)
Chain B
2–150(149 aa)
Chain C
2–150(149 aa)
|
Not recorded | FK2 3-oxidanylidenepropanoic acid × 2 A1BXY prop-2-ynoic acid × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;0.05 M citric acid, 0.05 M BIS-TRIS propane) pH 6 17% w/v PEG 3,355
|
Resolution 2.30 Å R-free 0.276 |
| 9NFF Native cis-CaaD with acetylenecarboxylic acid substrate Deposited 2025-02-21 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–150(149 aa)
Chain B
2–150(149 aa)
Chain C
2–150(149 aa)
|
Not recorded | A1BXY prop-2-ynoic acid × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;0.2 M ammonium tartrate dibasic, 20% w/v PEG 3,353
|
Resolution 2.00 Å R-free 0.262 |
| 9NFH Native cis-CaaD Deposited 2025-02-21 | Different construct Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–150(149 aa)
|
Not recorded | ACT ACETATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;0.18 M ammonium acetate 16% PEG 3,352
|
Resolution 1.32 Å R-free 0.213 |
| 9NG4 cis-CaaD Y103F mutant apo Deposited 2025-02-21 | Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–150(149 aa)
Chain B
2–150(149 aa)
Chain C
2–150(149 aa)
|
Mutation:Y103F Mutation:Y103F Mutation:Y103F | SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;0.2 M sodium fluoride 20% w/v PEG 3,350
|
Resolution 2.20 Å R-free 0.274 |
| 9NG5 cis-CaaD Y103F mutant soaked with acetylencarboxylic acid Deposited 2025-02-21 | Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–150(149 aa)
Chain B
2–150(149 aa)
Chain C
2–150(149 aa)
|
Not recorded | SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.2 M magnesium sulfate hep-tahydrate 20% w/v PEG 3,350
|
Resolution 2.28 Å R-free 0.354 |
| 9NG7 cis-CaaD H28A mutant Deposited 2025-02-21 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–150(149 aa)
Chain B
2–150(149 aa)
Chain C
2–150(149 aa)
|
Not recorded | ACT ACETATE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;0.2 M ammonium acetate 20% w/v PEG 3,350
|
Resolution 1.80 Å R-free 0.231 |
| 9NG8 cis-CaaD T34A mutant apo Deposited 2025-02-21 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
1–150(150 aa)
Chain B
1–150(150 aa)
Chain C
1–150(150 aa)
|
Mutation:T34A Mutation:T34A Mutation:T34A | SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.2 M ammonium sulfate 20% w/v PEG 3,350
|
Resolution 2.51 Å R-free 0.283 |
| 9NG9 cis-CaaD T34A mutant soaked with acetylenecarboxylic acid Deposited 2025-02-21 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
1–150(150 aa)
Chain B
1–150(150 aa)
Chain C
1–150(150 aa)
|
Mutation:T34A Mutation:T34A Mutation:T34A | SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.2 M ammonium sulfate 20% w/v PEG 3,350
|
Resolution 2.35 Å R-free 0.280 |
| 9NGA cis-CaaD T34A mutant soaked with cis-3-chloroacrylic acid Deposited 2025-02-21 | Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–150(149 aa)
Chain B
2–150(149 aa)
Chain C
2–150(149 aa)
|
Mutation:T34A Mutation:T34A Mutation:T34A | SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.2 M ammonium sulfate 20% w/v PEG 3,350
|
Resolution 2.40 Å R-free 0.308 |
| 9NGB truncated cis-CaaD Deposited 2025-02-21 | Different construct Different mutation/modification Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–120(119 aa)
|
Not recorded | SO4 SULFATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;0.2 M ammonium sulfate 20% w/v PEG 3,350
|
Resolution 2.50 Å R-free 0.301 |
| 9NGD cis-CaaD/Cg10062 chimera Deposited 2025-02-22 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–120(119 aa)
|
Not recorded | CL CHLORIDE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;0.2 M lithium chloride 20% w/v PEG 3,350
|
Resolution 2.70 Å R-free 0.336 |
| 9NGL cis-CaaD E114Q Deposited 2025-02-22 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–150(149 aa)
Chain B
2–150(149 aa)
Chain C
2–150(149 aa)
|
Mutation:E114Q Mutation:E114Q Mutation:E114Q | PO4 PHOSPHATE ION × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;(0.05 M citric acid, 0.05 M BIS-TRIS propane) pH 5 20% w/v PEG 3,354
|
Resolution 1.80 Å R-free 0.215 |
| 9O2N cis-CaaD Y103F mutant soaked with cis-3-chloroacrylic acid Deposited 2025-04-04 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–150(149 aa)
Chain B
2–150(149 aa)
Chain C
2–150(149 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;296 K;0.2 M sodium fluoride 20% w/v PEG 3,350
|
Resolution 2.20 Å R-free 0.237 |
| 9YRJ Cis-CaaD E114Q mutant with a covalent hydroxypropionate intermediate of the hydration of acetylenecarboxylic acid Deposited 2025-10-16 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–150(149 aa)
Chain B
2–150(149 aa)
Chain C
2–150(149 aa)
|
Mutation:E114Q Mutation:E114Q Mutation:E114Q | 3OH 3-HYDROXY-PROPANOIC ACID × 3 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;(0.05 M citric acid, 0.05 M BIS-TRIS propane) pH 5 20% w/v PEG 3,350
|
Resolution 1.93 Å R-free 0.240 |
| 9YTU cis-CaaD E114D mutant with a covalent intermediates of the hydration of acetylenecarboxylic acid Deposited 2025-10-21 | Different mutation/modification Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
2–150(149 aa)
Chain B
2–150(149 aa)
Chain C
2–150(149 aa)
|
Mutation:E114D Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:E114D Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:E114D | A1BXY prop-2-ynoic acid × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;0.2 M ammonium sulfate 20% w/v PEG 3,360
|
Resolution 2.51 Å R-free 0.260 |
20 other PDB entries and 20 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | Q6VPE5_9CORY |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–149; UniProt 2–150 Author chain B; PDBConstruct 1–149; UniProt 2–150 Author chain C; PDBConstruct 1–149; UniProt 2–150 |